Analysis of Percutaneous Ablations for Cancer Treatment
Status
Conditions
Study type
Funder types
Identifiers
Details and patient eligibility
About
This is a study involving patients with cancer who are referred by their treating physician for percutaneous locoregional therapies.
Patient's clinical and radiology findings, pathology findings, survival, treatment responses, and complications after their locoregional therapy will be studied.
Full description
The efficacy of the percutaneous and transarterial treatments for solid tumors will be studied. Prospective study on patients who receive percutaneous locoregional therapies, including radiofrequency ablation (RFA), cryoablation, microwave ablation, IRE and chemical ablation for treatment of cancer will be performed.
Preoperative clinic chart, procedure note, postoperative chart, pre- and post-operative CT, MRI or Ultrasound, angiographic findings, biopsy results and pathologic findings, will be reviewed. Patient survival, treatment responses, complications after the therapy will be collected from clinic visits and clinical encounters.
Patient overall performance status before and after procedures will be assessed using the Quality of Life questionnaire (SF-36™ Health Survey).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- 18yrs of age
- Cancer diagnosis
- Candidate for Locoregional therapy
- Willingness to sign informed consent
Exclusion criteria
- Unable to sign informed consent
- Patients not eligible for locoregional therapies
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal